RMD1501
Asset
Promotes neuroprotection and neuro-regeneration in cerebral ischemia.
- Stage
- Preclinical
- Modality
- Not known
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Ischemic stroke
Preclinical, remedium-bio.com, 10 Oct 2026
In the full profile
- Owner and partners1
Every asset’s record: target, stage, trials and the evidence behind it.